Novartis receives FDA approval for Signifor LAR to treat acromegaly
Swiss drugmaker Novartis has received approval from US Food and Drug Administration (FDA) for its Signifor long-acting release LAR (pasireotide) for injectable suspension and intramuscular use to treat patients with acromegaly. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - December 17, 2014 Category: Pharmaceuticals Source Type: news
Gene Discovery in Giants Could Shed Light on Human GrowthGene Discovery in Giants Could Shed Light on Human Growth
A duplication in a gene on the X chromosome is associated with an early-onset form of gigantism; the discovery is likely to shed light on how growth hormone is regulated, the researchers say. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - December 9, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Genetic basis for gigantism identified
Researchers at the National Institutes of Health have found a duplication of a short stretch of the X chromosome in some people with a rare disorder that causes excessive childhood growth; their study was published this week in The New England Journal of Medicine. Medical Xpress (Source: Society for Endocrinology)
Source: Society for Endocrinology - December 9, 2014 Category: Endocrinology Source Type: news
This Week: CDC Says Severe Flu Season Possible
(MedPage Today) -- The CDC warns about the coming flu season, and researchers report on a possible cause of gigantism in children. (Source: MedPage Today Public Health)
Source: MedPage Today Public Health - December 5, 2014 Category: American Health Source Type: news
Duplication of gene on X chromosome causes gigantism
Brooks HaysBETHESDA, Md., Dec. 4 (UPI) -- Researchers now believe gene duplication in a specific chromosome region, key in growth regulation, is responsible for the rare disorder known as gigantism. (Source: Health News - UPI.com)
Source: Health News - UPI.com - December 4, 2014 Category: Consumer Health News Source Type: news
Duplication Error May Make Giants
(MedPage Today) -- Novel mutation may underlie some cases of gigantism. (Source: MedPage Today Pediatrics)
Source: MedPage Today Pediatrics - December 4, 2014 Category: Pediatrics Source Type: news
NIH researchers link chromosome region to gigantism
Duplication of gene on X chromosome appears to cause excessive growth (Source: National Institutes of Health (NIH) News Releases)
Source: National Institutes of Health (NIH) News Releases - December 4, 2014 Category: American Health Source Type: news
Scientists May Have Spotted Genetic Cause of 'Gigantism'
Title: Scientists May Have Spotted Genetic Cause of 'Gigantism'Category: Health NewsCreated: 12/3/2014 12:00:00 AMLast Editorial Review: 12/4/2014 12:00:00 AM (Source: MedicineNet Kids Health General)
Source: MedicineNet Kids Health General - December 4, 2014 Category: Pediatrics Source Type: news
Novartis received EU approval for drug that treats rare hormonal disorder
Novartis International has announced that it has received approval from the European Commission for its drug called Signifor to treat the rare hormonal disorder acromegaly.
HNGN (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 25, 2014 Category: Endocrinology Source Type: news
European Commission grants approval for Novartis's Signifor to treat acromegaly
Swiss drug-maker Novartis has received approval from European Commission for its Signifor (pasireotide) intramuscular injection to treat adult patients suffering from acromegaly. (Source: Pharmaceutical Technology)
Source: Pharmaceutical Technology - November 25, 2014 Category: Pharmaceuticals Source Type: news
New guidelines for acromegaly include advice on pregnancy
The European Society of Endocrinology and the Endocrine Society have cosponsored a clinical practice guideline for the diagnosis and treatment of acromegaly. This is now available online in the Journal of Clinical Endocrinology & Metabolism. JCEM (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 11, 2014 Category: Endocrinology Source Type: news
New Guidelines for Acromegaly Include Advice on PregnancyNew Guidelines for Acromegaly Include Advice on Pregnancy
The US Endocrine Society issues first-ever guidance on management of acromegaly, cosponsored by the European Society of Endocrinology. Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 10, 2014 Category: Consumer Health News Tags: Diabetes & Endocrinology News Source Type: news
Acromegaly diagnosis and treatment guideline issued by The Endocrine Society
A new clinical practice guideline developed by The Endocrine Society and published in the Journal of Clinical Endocrinology & Metabolism addresses evaluation and management of acromegaly. Healio (Source: Society for Endocrinology)
Source: Society for Endocrinology - November 6, 2014 Category: Endocrinology Source Type: news
Experts recommend tumour removal as first-line treatment for acromegaly
The Endocrine Society has today issued a Clinical Practice Guideline for the diagnosis and treatment of acromegaly, recommending that surgery to remove tumours from the pituitary gland should be the primary treatment for most patients. EurekAlert (Source: Society for Endocrinology)
Source: Society for Endocrinology - October 31, 2014 Category: Endocrinology Source Type: news
Experts recommend tumor removal as first-line treatment for acromegaly
(The Endocrine Society) The Endocrine Society today issued a Clinical Practice Guideline for the diagnosis and treatment of acromegaly, a rare condition caused by excess growth hormone in the blood. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - October 30, 2014 Category: Global & Universal Source Type: news
